PKC-PKD-NFκB signalling induces cardiomyocyte t-tubule loss via a conserved macropinocytic mechanism

Cardiovascular Research

3 June 2026
Organised by: Logo
ESC Journals CARDIOVASCULAR PHARMACOLOGY HEART FAILURE Chronic Heart Failure BASIC SCIENCE

Abstract

AbstractAims

Deterioration of transverse-axial tubules (t-tubules) contributes to insufficient excitation-contraction coupling in heart failure, yet the key signals and mechanisms remain unclear. Here, we aimed to identify the signalling pathways that trigger cardiomyocyte t-tubule loss and its underlying cellular process.

Methods and results

Adult rat, rabbit, and human ventricular cardiomyocytes and living myocardial slices were exposed to pharmacological activators of protein kinase C (PKC). PKC activation caused rapid t-tubule loss and impaired Ca2+ transients, which were prevented by inhibition of protein kinase D (PKD) or NFκB. RNA sequencing and phosphoprotein analysis showed activation and crosstalk between PKD-, ERK-, and NFκB-dependent pathways, with up-regulation of genes involved in membrane trafficking and endocytosis. Fluorescent dextran uptake assays revealed a clathrin-independent, PI3K- and myosin-I-dependent macropinocytic process whose rate matched the internalization of t-tubule membranes and which was blocked by NFκB inhibition. Constitutive activation of IKK2 in cardiomyocytes of transgenic mice reduced t-tubule density in vivo, confirming that prolonged NFκB activation is sufficient to induce t-tubule remodelling in intact hearts. NFκB inhibition suppressed PKC-induced macropinocytosis also in non-cardiac human cell lines, suggesting that this process represents a conserved cellular response to inflammatory signalling.

Conclusion

PKC-PKD-NFκB signalling triggers a macropinocytic form of membrane remodelling that degrades the t-tubule network and impairs excitation-contraction coupling. This identifies a previously unrecognized mechanism linking inflammatory kinase activation to structural and functional decline of cardiomyocytes and suggests that targeting the PKD-NFκB axis could preserve t-tubule integrity and cardiac performance in heart failure.

Contributors